Literature DB >> 19741634

Globetrotting firms: Canada's health biotechnology collaborations with developing countries.

Monali Ray1, Abdallah S Daar, Peter A Singer, Halla Thorsteinsdóttir.   

Abstract

A survey of Canadian biotech firms reveals that their biotech collaborations with developing countries are not only significant but also increasingly reciprocal in terms of the exchange of financial resources and technological know-how.

Mesh:

Substances:

Year:  2009        PMID: 19741634     DOI: 10.1038/nbt0909-806

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  12 in total

1.  The scientific muscle of Brazil's health biotechnology.

Authors:  Marcela Ferrer; Halla Thorsteinsdóttir; Uyen Quach; Peter A Singer; Abdallah S Daar
Journal:  Nat Biotechnol       Date:  2004-12       Impact factor: 54.908

2.  India's health biotech sector at a crossroads.

Authors:  Sarah E Frew; Rahim Rezaie; Stephen M Sammut; Monali Ray; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2007-04       Impact factor: 54.908

Review 3.  Brazilian health biotech--fostering crosstalk between public and private sectors.

Authors:  Rahim Rezaie; Sarah E Frew; Stephen M Sammut; Maya R Maliakkal; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2008-06       Impact factor: 54.908

4.  A survey of South-North health biotech collaboration.

Authors:  Christina C Melon; Monali Ray; Sharon Chakkalackal; Michelle Li; Jan E Cooper; Jennifer Chadder; Wen Ke; Lexuan Li; Magdy A Madkour; Sahar Aly; Nefertiti Adly; Sachin Chaturvedi; Victor Konde; Abdallah S Daar; Peter A Singer; Halla Thorsteinsdóttir
Journal:  Nat Biotechnol       Date:  2009-03       Impact factor: 54.908

5.  North-South partnerships--a study of Canadian firms.

Authors:  Andrew D Taylor; David Brook; David Watters; Elizabeth Dowdeswell; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2007-09       Impact factor: 54.908

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  Health biotechnology in China--reawakening of a giant.

Authors:  Li Zhenzhen; Zhang Jiuchun; Wen Ke; Halla Thorsteinsdóttir; Uyen Quach; Peter A Singer; Abdallah S Daar
Journal:  Nat Biotechnol       Date:  2004-12       Impact factor: 54.908

8.  Conclusions: promoting biotechnology innovation in developing countries.

Authors:  Halla Thorsteinsdóttir; Uyen Quach; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2004-12       Impact factor: 54.908

Review 9.  Epidemiology of severe acute respiratory syndrome (SARS): adults and children.

Authors:  Nan-Shan Zhong; Gary W K Wong
Journal:  Paediatr Respir Rev       Date:  2004-12       Impact factor: 2.726

Review 10.  Chinese health biotech and the billion-patient market.

Authors:  Sarah E Frew; Stephen M Sammut; Alysha F Shore; Joshua K Ramjist; Sara Al-Bader; Rahim Rezaie; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2008-01       Impact factor: 54.908

View more
  3 in total

1.  South-South entrepreneurial collaboration in health biotech.

Authors:  Halla Thorsteinsdóttir; Christina C Melon; Monali Ray; Sharon Chakkalackal; Michelle Li; Jan E Cooper; Jennifer Chadder; Tirso W Saenz; Maria Carlota de Souza Paula; Wen Ke; Lexuan Li; Magdy A Madkour; Sahar Aly; Nefertiti El-Nikhely; Sachin Chaturvedi; Victor Konde; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

Review 2.  Health biotechnology innovation on a global stage.

Authors:  Halla Thorsteinsdóttir; Monali Ray; Andrew Kapoor; Abdallah S Daar
Journal:  Nat Rev Microbiol       Date:  2011-02       Impact factor: 60.633

3.  Biomedical research, a tool to address the health issues that affect African populations.

Authors:  Emmanuel Peprah; Ambroise Wonkam
Journal:  Global Health       Date:  2013-10-21       Impact factor: 4.185

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.